Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H I Robins

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|January 1, 1996
Hematological effects of radiant heat-induced whole body hyperthermia on dogsJ P Woods, C L Schmitt-Tiggelaar, F d'Oleire, et al.
Human Immunology|July 1, 1987
Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cellsR B Mandell, J A Hank, B P Chen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustardM E Kutz, D L Mulkerin, G J Wiedemann, et al.
Investigational New Drugs|November 1, 1990
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group studyH I Robins, D S Neuberg, A B Benson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Heat shock protein antibodies in sarcoma patients undergoing 41.8 degrees C whole body hyperthermiaD M Katschinski, R Benndorf, G J Wiedemann, et al.
Oncology|May 1, 1996
Local hyperthermia, radiation, and chemotherapy in locally advanced malignanciesT Feyerabend, R Steeves, G J Wiedemann, et al.
British Journal of Cancer|September 1, 1991
Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrowE Tapazoglou, J D Cohen, C L Schmitt, et al.
Cancer Letters|May 19, 1997
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermiaD M Katschinski, G J Wiedemann, M Mentzel, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 9, 1998
Influence of circadian rhythm on 41.8 degrees C whole body hyperthermia induction of haematopoietic growth factorsD M Katschinski, G J Wiedemann, M Mentzel, et al.
Cytokine & Growth Factor Reviews|April 1, 2000
Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapyD M Katschinski, G J Wiedemann, W Longo, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|January 1, 1996
Hematological effects of radiant heat-induced whole body hyperthermia on dogsJ P Woods, C L Schmitt-Tiggelaar, F d'Oleire, et al.
Human Immunology|July 1, 1987
Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cellsR B Mandell, J A Hank, B P Chen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustardM E Kutz, D L Mulkerin, G J Wiedemann, et al.
Investigational New Drugs|November 1, 1990
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group studyH I Robins, D S Neuberg, A B Benson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Heat shock protein antibodies in sarcoma patients undergoing 41.8 degrees C whole body hyperthermiaD M Katschinski, R Benndorf, G J Wiedemann, et al.
Oncology|May 1, 1996
Local hyperthermia, radiation, and chemotherapy in locally advanced malignanciesT Feyerabend, R Steeves, G J Wiedemann, et al.
British Journal of Cancer|September 1, 1991
Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrowE Tapazoglou, J D Cohen, C L Schmitt, et al.
Cancer Letters|May 19, 1997
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermiaD M Katschinski, G J Wiedemann, M Mentzel, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 9, 1998
Influence of circadian rhythm on 41.8 degrees C whole body hyperthermia induction of haematopoietic growth factorsD M Katschinski, G J Wiedemann, M Mentzel, et al.
Cytokine & Growth Factor Reviews|April 1, 2000
Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapyD M Katschinski, G J Wiedemann, W Longo, et al.
Pageof 12